Sierra Oncology, Inc. Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018	FY2017 12 months to Dec 31, 2017
Net loss
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation
Depreciation and amortization
Changes in fair value of warrant liabilities
Securities issuance obligation
Asset impairment
Warrant issuance costs
Term loan repayment fee
Other
Changes in operating assets and liabilities:
Prepaid expenses and other assets
Accrued, other and operating lease liabilities
Accounts payable
Net cash used in operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment
Change in restricted cash
Net cash (used in) provided by investing activities
Net cash used in investing activities

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of common stock, net of offering costs
At The Market Offering
Follow-on Offering
Total proceeds from issuance of common stock, net of offering costs

Proceeds from exercise of common stock options
Proceeds from issuance of term loan, net of issuance costs
Proceeds from exercise of common stock warrants
Effect of exchange rate changes on cash and cash equivalents
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS
CASH AND CASH EQUIVALENTS-Beginning of period
CASH AND CASH EQUIVALENTS-End of period
Proceeds from public offering, net of offering costs
Payment of term loan and repayment fee
Net cash provided by financing activities

Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS AND RESTRICTED CASH
CASH, CASH EQUIVALENTS AND RESTRICTED CASH — Beginning of period
CASH, CASH EQUIVALENTS AND RESTRICTED CASH — End of period
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for (refund of) income taxes, net
Cash paid for interest
SUPPLEMENTAL DISCLOSURES OF NON-CASH INVESTING AND FINANCING INFORMATION:
Right-of-use asset obtained in exchange for operating lease obligation
Property and equipment purchases included in accounts payable
Offering costs not yet paid
Issuance of common stock and common stock warrant in connection with an amendment to the asset purchase agreement
Reclassification of warrant liabilities to equity
Issuance costs of convertible voting preferred stock and warrants included in accrued and other liabilities
Issuance of common stock warrant

Comments